Latest Breaking News On - Mitsuyuki mickey matsumoto - Page 1 : comparemela.com

$58M Seed Launches Arialys - San Diego Business Journal

$58M Seed Launches Arialys - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

Al iskandariyahAstellas pharmaCatalys pacificMitsuyuki mickey matsumotoJay lichterAvalon bioventuresNeuroscience research unitJjdc incArialys therapeuticsSan diego based arialysJohnson innovationAlexandria ventureTokyo based astellas pharmaChief science officer mitsuyukiVirtual venture unit psychiatry

Arialys Therapeutics Closes $58M Seed Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Al iskandariyahAstellas pharmaCatalys pacificMitsuyuki mickey matsumotoJay lichterAvalon bioventuresJjdc incDrug administrationArialys therapeuticsJohnson innovationAlexandria ventureScientific founderChief scientific officer

Arialys Therapeutics Launches to Lead the Development of New Precision Medicines for Autoimmune Neuropsychiatric Diseases

Arialys Therapeutics Launches to Lead the Development of New Precision Medicines for Autoimmune Neuropsychiatric Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLa jollaAl iskandariyahMathew mitchellJessica yinglingMitsuyuki mickey matsumotoJay lichterAstellas pharmaTorrey pines mesaCatalys pacificAvalon bioventuresCorporate developmentHead of the neuroscience research unitDrug administrationLittle dog communications incJjdc inc

Neuro Startup Arialys Raises $58M for Privilege of Tackling Brain Inflammation

Avalon BioVentures unveiled new portfolio company Arialys Therapeutics. The startup’s lead program, an antibody from Astellas Pharma, is a potential treatment for anti-NMDA receptor encephalitis (ANRE), a rare autoimmune inflammatory disorder.

La jollaUnited statesNew yorkAl iskandariyahSan diegoRoghiye kazimiAmir razaiMitsuyuki mickey matsumotoJay lichterAstellas pharmaAvalon bioventuresCatalys pacificSusannah cahalanNew york postJjdc incArialys therapeutic amir razai